Exosome Display technology: Applications to the development of new diagnostics and therapeutics

Blood Cells, Molecules, and Diseases

Volumn 35, Issue 2, 2005, Pages 158-168

  Delcayre, Alain ^a,b   Estelles, Angeles ^a,c   Sperinde, Jeffrey ^a,d   Roulon, Thibaut ^a,e   Paz, Pedro ^a,f   Aguilar, Barbara ^a,g   Villanueva, Janeth ^a   Khine, SuSu ^a   Le Pecq, Jean Bernard ^a,b  

^a Anosys Inc   (United States)

^b ExoThera LLC   (United States)

^c Genitope Corporation   (United States)

^d MONOGRAM BIOSCIENCES   (United States)

^e Bioam   (France)

^f Medarex ^*  (United States)

^g Medarex Inc   (United States)

Author keywords

Antibody; ExoMAb; Lactadherin; Nanotechnology; Targeting

Indexed keywords

ANTIGEN; BIOLOGICAL MARKER; G PROTEIN COUPLED RECEPTOR; HYBRID PROTEIN; LACTADHERIN; LIPID; MEMBRANE ANTIGEN; MEMBRANE PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL COMPOSITION; CELL VACUOLE; DIAGNOSTIC TEST; EXOSOME; EXOSOME DISPLAY TECHNOLOGY; HLA SYSTEM; HUMAN; HUMAN CELL; MAMMARY GLAND; METHODOLOGY; MOUSE; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN CONTENT; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TECHNOLOGY;

ANTIBODIES; ANTIBODY FORMATION; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CELL LINE; ENDOSOMES; HLA ANTIGENS; HUMANS; IMMUNOTHERAPY; MEMBRANE PROTEINS; MILK PROTEINS; NEOPLASMS; PEPTIDE LIBRARY; RECOMBINANT FUSION PROTEINS;

EID: 24644464140     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2005.07.003     Document Type: Article

References (33)

1. R.M. Johnstone The Jeanne Manery-Fisher Memorial Lecture 1991. Maturation of reticulocytes: formation of exosomes as a mechanism for shedding membrane proteins Biochem. Cell Biol. 70 3-4 1992 179 190
2. A. Delcayre, H. Shu, and J.B. LePecq Dendritic cell-derived exosomes in cancer immunotherapy: exploiting Nature's antigen delivery pathway Expert Rev. Anticancer Ther. 5 3 2005
3. C. Théry, Z. Zitvogel, and S. Amigorena Exosomes: composition, biogenesis and function Nat. Rev., Immunol. 2 8 2002 569 579
4. M.A. Morse, J. Garst, and T. Osada A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer J. Transl. Med. 3 1 2005 9
5. B. Escudier, T. Dorval, and N. Chaput Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived exosomes: results of the first phase I clinical trial J. Transl. Med. 3 1 2005 10
6. C. Thery, M. Boussac, P. Veron, P. Ricciardi-Castagnoli, G. Raposo, J. Garin, and S. Amigorena Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles J. Immunol. 166 12 2001 7309 7318
7. H.G. Lamparski, A. Metha-Damani, and J.Y. Yao Production and characterization of clinical grade exosomes derived from dendritic cells J. Immunol. Methods 270 2 2002 211 226
8. C. Thery, L. Duban, E. Segura, P. Veron, O. Lantz, and S. Amigorena Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes Nat. Immunol. 3 2002 1156 1162
9. H. Vincent-Schneider, P. Stumptner-Cuvelette, D. Lankar, S. Pain, G. Raposo, P. Benaroch, and C. Bonnerot Exosomes bearing HLA-DR1 molecules need dendritic cells to efficiently stimulate specific T cells Int. Immunol. 14 7 2002 713 722
10. D.H. Hsu, P. Paz, and G. Villaflor Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides J. Immunother. 26 5 2003 440 450
11. F. Andre, N. Chaput, and N.E. Schartz Exosomes as potent cell-free peptide-based vaccine: I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells J. Immunol. 172 4 2004 2126 2136
12. R. Wubbolts, R.S. Leckie, and P.T. Veenhuizen Proteomic and biochemical analyses of human B cell-derived exosomes, potential implications for their function and multivesicular body formation J. Biol. Chem. 278 13 2003 10963 10972
13. L. Frangsmyr, V. Baranov, O. Nagaeva, U. Stendahl, L. Kjellberg, and L. Mincheva-Nilsson Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level Mol. Hum. Reprod. 11 1 2005 35 41
14. A. Janowska-Wieczorek, M. Wysoczynski, J. Kijowski, L. Marquez-Curtis, B. Machalinski, J. Ratajczak, and M.Z. Ratajczak Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer Int. J. Cancer 113 5 2005 752 760
15. J. Mallegol, G. van Niel, and M. Heyman Phenotypic and functional characterization of intestinal epithelial exosomes Blood Cells Mol. Dis. 2005 (May 10) (Electronic publication ahead of print)
16. D.G. Nguyen, A. Booth, S.J. Gould, and J.E. Hildreth Evidence that HIV budding in primary macrophages occurs through the exosome release pathway J. Biol. Chem. 278 52 2003 52347 52354
17. F. Masciopinto, C. Giovani, and S. Campagnoli Association of hepatitis C virus envelope proteins with exosomes Eur. J. Immunol. 34 10 2004 2834 2842
18. A. Pelchen-Matthews, G. Raposo, and M. Marsh Endosomes, exosomes and Trojan viruses Trends Microbiol. 12 7 2004 310 316
19. J. Flanagan, J. Middeldorp, and T. Sculley Localization of the Epstein-Barr virus protein LMP 1 to exosomes J. Gen. Virol. 84 2003 1871 1879
20. G. Andreola, L. Rivoltini, and C. Castelli Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles J. Exp. Med. 195 10 2002 1303 1316
21. P. Gutwein, A. Stoeck, and S. Riedle Cleavage of l1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells Clin. Cancer Res. 11 7 2005 2492 2501
22. H. Peche, M. Heslan, C. Usal, S. Amigorena, and M.C. Cuturi Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection Transplantation 76 10 2003 1503 1510
23. S.J. Gould, A.M. Booth, and J.E. Hildreth The Trojan exosome hypothesis Proc. Natl. Acad. Sci. U. S. A. 100 19 2003 10592 10597
24. E. Morita, and W.I. Sundquist Retrovirus budding Annu. Rev. Cell Dev. Biol. 20 2004 395 425
25. D.D. Taylor, and C. Gercel-Taylor Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects Br. J. Cancer 92 2 2005 305 311
26. A.H. Yin, S. Miraglia, and E.D. Zanjani AC133, a novel marker for human hematopoietic stem and progenitor cells Blood 90 12 1997 5002 50012
27. K.P. Pratt, B.W. Shen, K. Takeshima, E.W. Davie, K. Fujikawa, and B.L. Stoddard Structure of the C2 domain of human factor VIII at 1.5 A resolution Nature 402 6760 1999 439 442
28. A. Srivastava, M.A. Quinn-Allen, S.W. Kim, W.H. Kane, and B.R. Lentz Soluble phosphatidylserine binds to a single identified site in the C2 domain of human factor Va Biochemistry 40 28 2001 8246 8255
29. S. Takagi, T. Hirata, K. Agata, M. Mochii, G. Eguchi, and H. Fujisawa The A5 antigen, a candidate for the neuronal recognition molecule, has homologies to complement components and coagulation factors Neuron 7 2 1991 295 307
30. C. Hidai, T.J. Zupancic, and K. Penta Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor Genes Dev. 12 1 1998 21 33
31. J.P. Hegmans, M.P. Bard, and A. Hemmes Proteomic analysis of exosomes secreted by human mesothelioma cells Am. J. Pathol. 164 5 2004 1807 1815
32. A. Delcayre, J.B. LePecq, Methods and compounds for the targeting of proteins to exosomes. USPTO. Electronic publication W0 03/016522 (2003).
33. P. Kavathas, F.H. Bach, and R. DeMars Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells Proc. Natl. Acad. Sci. U. S. A. 77 7 1980 4251 4255